Carroll C - Search Results

1

Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical Trial.

Stevens KN, Creanor S, Jeffery A, Whone A, Zajicek J, Foggo A, Jones B, Chapman R, Cocking L, Wilks J, Webb D, Carroll C; PD STAT Study Group. Stevens KN, et al. Among authors: carroll c. JAMA Neurol. 2022 Dec 1;79(12):1232-1241. doi: 10.1001/jamaneurol.2022.3718. JAMA Neurol. 2022. PMID: 36315128 Free PMC article. Clinical Trial.

2

Provision of 24 hour acute neurology care by neurologists: manpower requirements in the UK.

Carroll C, Zajicek J. Carroll C, et al. J Neurol Neurosurg Psychiatry. 2004 Mar;75(3):406-9. doi: 10.1136/jnnp.2003.018010. J Neurol Neurosurg Psychiatry. 2004. PMID: 14966156 Free PMC article.

3

The effect of cannabis on tremor in patients with multiple sclerosis.

Fox P, Bain PG, Glickman S, Carroll C, Zajicek J. Fox P, et al. Among authors: carroll c. Neurology. 2004 Apr 13;62(7):1105-9. doi: 10.1212/01.wnl.0000118203.67138.3e. Neurology. 2004. PMID: 15079008 Clinical Trial.

4

The 'harlequin' sign in association with multiple sclerosis.

Carroll CB, Zajicek JP. Carroll CB, et al. J Neurol. 2004 Sep;251(9):1145-6. doi: 10.1007/s00415-004-0486-0. J Neurol. 2004. PMID: 15372263 No abstract available.

5

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study.

Carroll CB, Bain PG, Teare L, Liu X, Joint C, Wroath C, Parkin SG, Fox P, Wright D, Hobart J, Zajicek JP. Carroll CB, et al. Neurology. 2004 Oct 12;63(7):1245-50. doi: 10.1212/01.wnl.0000140288.48796.8e. Neurology. 2004. PMID: 15477546 Clinical Trial.

6

Muscle cramps and weakness secondary to graft versus host disease fasciitis.

Carroll CB, Hilton DA, Hamon M, Zajicek JP. Carroll CB, et al. Eur J Neurol. 2005 Apr;12(4):320-2. doi: 10.1111/j.1468-1331.2004.00964.x. Eur J Neurol. 2005. PMID: 15804251 No abstract available.

7

Quantifying drug-induced dyskinesias in the arms using digitised spiral-drawing tasks.

Liu X, Carroll CB, Wang SY, Zajicek J, Bain PG. Liu X, et al. J Neurosci Methods. 2005 May 15;144(1):47-52. doi: 10.1016/j.jneumeth.2004.10.005. Epub 2004 Nov 28. J Neurosci Methods. 2005. PMID: 15848238

8

Quantifying the impact of dyskinesias in PD: the PDYS-26: a patient-based outcome measure.

Katzenschlager R, Schrag A, Evans A, Manson A, Carroll CB, Ottaviani D, Lees AJ, Hobart J. Katzenschlager R, et al. Among authors: carroll cb. Neurology. 2007 Aug 7;69(6):555-63. doi: 10.1212/01.wnl.0000266669.18308.af. Neurology. 2007. PMID: 17679674

9

Designing clinical trials in older people.

Carroll CB, Zajicek JP. Carroll CB, et al. Maturitas. 2011 Apr;68(4):337-41. doi: 10.1016/j.maturitas.2011.02.002. Epub 2011 Mar 3. Maturitas. 2011. PMID: 21376485 Review.

10

Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease.

Carroll CB, Zeissler ML, Hanemann CO, Zajicek JP. Carroll CB, et al. Neuropathol Appl Neurobiol. 2012 Oct;38(6):535-47. doi: 10.1111/j.1365-2990.2011.01248.x. Neuropathol Appl Neurobiol. 2012. PMID: 22236282

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,220 results

Search Page